StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BofA Securities remains Neutral on Johnson & Johnson (JNJ): early Ico approval was 'modest upside'
March 18, 2026 11:26 AM
BofA Securities analyst Jason M. Gerberry reiterated a Neutral rating and $253.00 price target on Johnson & Johnson (NYSE: JNJ)The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
